RSS feed

Publications (original articles or review articles) published in 2021 from OUS - Dept. of Microbiology, Dudman - Clinical Virology Research Group

23 publications found

Avershina E, Sharma P, Taxt AM, Singh H, Frye SA, Paul K, Kapil A, Naseer U, Kaur P, Ahmad R (2021)
AMR-Diag: Neural network based genotype-to-phenotype prediction of resistance towards β-lactams in Escherichia coli and Klebsiella pneumoniae
Comput Struct Biotechnol J, 19, 1896-1906
DOI 10.1016/j.csbj.2021.03.027, PubMed 33897984

Barratt-Due A, Olsen IC, Nezvalova-Henriksen K, Kåsine T, Lund-Johansen F, Hoel H, Holten AR, Tveita A, Mathiessen A, Haugli M, Eiken R, Kildal AB, Berg Å, Johannessen A, Heggelund L, Dahl TB, Skåra KH, Mielnik P, Le LAK, Thoresen L, Ernst G, Hoff DAL, Skudal H, Kittang BR, Olsen RB et al. (2021)
Evaluation of the Effects of Remdesivir and Hydroxychloroquine on Viral Clearance in COVID-19 : A Randomized Trial
Ann Intern Med, 174 (9), 1261-1269
DOI 10.7326/M21-0653, PubMed 34251903

Benschop KSM, Broberg EK, Hodcroft E, Schmitz D, Albert J, Baicus A, Bailly JL, Baldvinsdottir G, Berginc N, Blomqvist S, Böttcher S, Brytting M, Bujaki E, Cabrerizo M, Celma C, Cinek O, Claas ECJ, Cremer J, Dean J, Dembinski JL, Demchyshyna I, Diedrich S, Dudman S, Dunning J, Dyrdak R et al. (2021)
Molecular Epidemiology and Evolutionary Trajectory of Emerging Echovirus 30, Europe
Emerg Infect Dis, 27 (6), 1616-1626
DOI 10.3201/eid2706.203096, PubMed 34013874

Bjørkto MH, Barratt-Due A, Nordøy I, Dörje C, Galteland E, Lind A, Hilli A, Aukrust P, Mjøen G (2021)
The use of eculizumab in Capnocytophaga canimorsus associated thrombotic microangiopathy: a case report
BMC Infect Dis, 21 (1), 137
DOI 10.1186/s12879-021-05789-2, PubMed 33526010

Borud EK, Nakstad ER, Håberg SE, Lind A, Fadum EA, Taxt AM, Steens A, Gjein GE, Sunde MW, Iversen P, Svanevik M, Ahmad BM, Waldow T, Norheim AJ (2021)
Severe acute respiratory syndrome coronavirus 2 prevalence in 1170 asymptomatic Norwegian conscripts
Health Sci Rep, 4 (1), e233
DOI 10.1002/hsr2.233, PubMed 33490637

Brandal LT, MacDonald E, Veneti L, Ravlo T, Lange H, Naseer U, Feruglio S, Bragstad K, Hungnes O, Ødeskaug LE, Hagen F, Hanch-Hansen KE, Lind A, Watle SV, Taxt AM, Johansen M, Vold L, Aavitsland P, Nygård K, Madslien EH (2021)
Outbreak caused by the SARS-CoV-2 Omicron variant in Norway, November to December 2021
Euro Surveill, 26 (50)
DOI 10.2807/1560-7917.ES.2021.26.50.2101147, PubMed 34915975

Christensen EE, Jørgensen MJ, Nore KG, Dahl TB, Yang K, Ranheim T, Huse C, Lind A, Nur S, Stiksrud B, Jenum S, Tonby K, Holter JC, Holten AR, Halvorsen B, Dyrhol-Riise AM (2021)
Critical COVID-19 is associated with distinct leukocyte phenotypes and transcriptome patterns
J Intern Med, 290 (3), 677-692
DOI 10.1111/joim.13310, PubMed 34080738

Debes S, Haug JB, de Blasio BF, Jonassen CM, Dudman SG (2021)
Etiology of viral respiratory tract infections in hospitalized adults, and evidence of the high frequency of prehospitalization antibiotic treatment in Norway
Health Sci Rep, 4 (4), e403
DOI 10.1002/hsr2.403, PubMed 34646942

Eliassen KE, Ocias LF, Krogfelt KA, Wilhelmsson P, Dudman SG, Andreassen Å, Lindbak M, Lindgren PE (2021)
Tick-transmitted co-infections among erythema migrans patients in a general practice setting in Norway: a clinical and laboratory follow-up study
BMC Infect Dis, 21 (1), 1044
DOI 10.1186/s12879-021-06755-8, PubMed 34625049

ISARIC Clinical Characterisation Group (2021)
The value of open-source clinical science in pandemic response: lessons from ISARIC
Lancet Infect Dis, 21 (12), 1623-1624
DOI 10.1016/S1473-3099(21)00565-X, PubMed 34619109

ISARIC Clinical Characterisation Group, Hall MD, Baruch J, Carson G, Citarella BW, Dagens A, Dankwa EA, Donnelly CA, Dunning J, Escher M, Kartsonaki C, Merson L, Pritchard M, Wei J, Horby PW, Rojek A, Olliaro PL (2021)
Ten months of temporal variation in the clinical journey of hospitalised patients with COVID-19: An observational cohort
Elife, 10
DOI 10.7554/eLife.70970, PubMed 34812731

Knudsen PK, Lind A, Klundby I, Dudman S (2021)
The incidence of infectious diseases and viruses other than SARS-CoV-2 amongst hospitalised children in Oslo, Norway during the Covid-19 pandemic 2020-2021
J Clin Virol Plus, 2 (1), 100060
DOI 10.1016/j.jcvp.2021.100060, PubMed 35262033

Landaas ET, Storm ML, Tollånes MC, Barlinn R, Kran AB, Bragstad K, Christensen A, Andreassen T (2021)
Diagnostic performance of a SARS-CoV-2 rapid antigen test in a large, Norwegian cohort
J Clin Virol, 137, 104789
DOI 10.1016/j.jcv.2021.104789, PubMed 33736946

Lind A, Barlinn R, Landaas ET, Andresen LL, Jakobsen K, Fladeby C, Nilsen M, Bjørnstad PM, Sundaram AYM, Ribarska T, Müller F, Gilfillan GD, Holberg-Petersen M (2021)
Rapid SARS-CoV-2 variant monitoring using PCR confirmed by whole genome sequencing in a high-volume diagnostic laboratory
J Clin Virol, 141, 104906
DOI 10.1016/j.jcv.2021.104906, PubMed 34273860

Nakanishi T, Pigazzini S, Degenhardt F, Cordioli M, Butler-Laporte G, Maya-Miles D, Bujanda L, Bouysran Y, Niemi ME, Palom A, Ellinghaus D, Khan A, Martínez-Bueno M, Rolker S, Amitrano S, Roade Tato L, Fava F, FinnGen, COVID-19 Host Genetics Initiative (HGI), Spinner CD, Prati D, Bernardo D, Garcia F, Darcis G, Fernández-Cadenas I et al. (2021)
Age-dependent impact of the major common genetic risk factor for COVID-19 on severity and mortality
J Clin Invest, 131 (23)
DOI 10.1172/JCI152386, PubMed 34597274

Norheim AJ, Borud EK, Lind A, Fadum EA, Taxt A, Steens A, Bragstad K, Rein E, Nakstad E (2021)
Pre-screening and preventive quarantine likely explains the low SARS-CoV-2 prevalence among Norwegian conscripts
Scand J Prim Health Care, 39 (1), 31-34
DOI 10.1080/02813432.2021.1880101, PubMed 33544016

Oppen K, Ueland T, Siljan WW, Skadberg Ø, Brede C, Lauritzen T, Aukrust P, Steinsvik T, Husebye E, Michelsen AE, Holter JC, Heggelund L (2021)
Hepcidin and Ferritin Predict Microbial Etiology in Community-Acquired Pneumonia
Open Forum Infect Dis, 8 (4), ofab082
DOI 10.1093/ofid/ofab082, PubMed 33880390

Ramstad SN, Brandal LT, Taxt AM, Wasteson Y, Bjørnholt JV, Naseer U (2021)
Prevalence of genotypic antimicrobial resistance in clinical Shiga toxin-producing Escherichia coli in Norway, 2018 to 2020
J Med Microbiol, 70 (12)
DOI 10.1099/jmm.0.001454, PubMed 34870582

Ramstad SN, Wasteson Y, Lindstedt BA, Taxt AM, Bjørnholt JV, Brandal LT, Bohlin J (2021)
Characterization of Shiga Toxin 2a Encoding Bacteriophages Isolated From High-Virulent O145:H25 Shiga Toxin-Producing Escherichia coli
Front Microbiol, 12, 728116
DOI 10.3389/fmicb.2021.728116, PubMed 34566932

Shrestha J, Shrestha SK, Strand TA, Dudman S, Dembinski JL, Vikse R, Andreassen AK (2021)
Diversity of Rotavirus Strains in Children; Results From a Community-Based Study in Nepal
Front Med (Lausanne), 8, 712326
DOI 10.3389/fmed.2021.712326, PubMed 34660624

Søraas A, Kalleberg KT, Dahl JA, Søraas CL, Myklebust TÅ, Axelsen E, Lind A, Bævre-Jensen R, Jørgensen SB, Istre MS, Kjetland EF, Ursin G (2021)
Persisting symptoms three to eight months after non-hospitalized COVID-19, a prospective cohort study
PLoS One, 16 (8), e0256142
DOI 10.1371/journal.pone.0256142, PubMed 34437579

Aamodt AH, Høgestøl EA, Popperud TH, Holter JC, Dyrhol-Riise AM, Tonby K, Stiksrud B, Quist-Paulsen E, Berge T, Barratt-Due A, Aukrust P, Heggelund L, Blennow K, Zetterberg H, Harbo HF (2021)
Blood neurofilament light concentration at admittance: a potential prognostic marker in COVID-19
J Neurol, 268 (10), 3574-3583
DOI 10.1007/s00415-021-10517-6, PubMed 33743046

Aarskog NR, Aass HC, Holter JC, Rostrup M, Holten AR (2021)
Interleukin-6 in Critical Coronavirus Disease 2019, a Driver of Lung Inflammation of Systemic Origin?
Crit Care Explor, 3 (10), e0542
DOI 10.1097/CCE.0000000000000542, PubMed 34604785